Morning, Wednesday, 16th September 2020
THIS EVENT IS CPD CERTIFIED
This conference will examine the use of technology, artificial intelligence, and genomics to improve the diagnosis of disease.
It will be an opportunity to discuss the Medicines and Medical Devices Bill currently before parliament, which aims to develop advanced therapies and rapid diagnostics in the UK through:
- streamlining regulation;
- support for research and the life sciences sector; and
- making it easier for hospitals to trial new personalised medicines.
We also expect discussion on the next steps for meeting the commitment in the NHS Long Term Plan to implement pathology networks across England by 2021, and diagnostic imaging networks by 2023.
Speakers and chair
The agenda includes keynote addresses from:
- Professor Sir Mark Caulfield, Chief Scientist, Genomics England;
- Professor Jo Martin, President, Royal College of Pathologists; and
- Dr Saoirse Dolly, Consultant, Rapid Access Diagnostic Clinic, Guy’s and St Thomas’ NHS Foundation Trust.
Further speakers include: Emma Cox, Endometriosis UK and Luella Trickett, Association of British Healthcare Industries.
The agenda in summary
- Rolling out imaging and pathology networks:
- Integration, utilising shared resources and the role of technology; and
- Consolidating pathology services, and supporting staff recruitment, development, and retention.
- Improving diagnostic times for cancer and learning from Rapid Diagnostic Centres;
- Accelerating the diagnostic process - research funding, developing standards, and upgrading infrastructure;
- Innovation in diagnostics and pathology - utilising data and artificial intelligence, encouraging uptake, and developing personalised treatments; and
- Evaluating diagnostic technologies and assessing barriers to adoption.
Engagement with policy officials at this conference
This Westminster Health Forum conference has attracted strong interest from policymakers. It will be an opportunity for stakeholders to engage with officials who have reserved places representing: DHSC; MHRA; Office for Life Sciences; Cabinet Office; BEIS; DIT; and the Welsh Government.